32
Immunologia TB/HIV Andrea Gori UO Mala/e Infe23ve AO San Gerardo, Monza Università MilanoBicocca [email protected] Milano, 2122 Marzo 2014

PPT Gori "Immunologia TB/HIV"

Embed Size (px)

DESCRIPTION

 

Citation preview

  • 1. ImmunologiaTB/HIV AndreaGori UOMala/eInfe23ve AOSanGerardo,Monza UniversitMilano-Bicocca [email protected] Milano,21-22Marzo2014 !

2. InterferonGammaReleaseAssay(IGRA)tes;ng 3. Clinicalu;lityofinterferongammarelease assays(IGRAs) 4. Biologicalphenomenaofmother-newbornimmune interac;onwhichcantheore;callyaectnewborn immuneresponsestomicrobialan;gens 5. Sensi;vityofIGRAsinHIV-infectedindividuals withconrmedac;vetuberculosis 6. Propor;onofindeterminateIGRAresultsin HIV-infectedpersonsscreenedforLTBI 7. ImpactofCD4+cellcountonthepropor;onof posi;veIGRAresults 8. ImpactofCD4+cellcountonthepropor;onof indeterminateIGRAresults 9. IGRAtestfortheDiagnosisofLTBIinHIV- InfectedIndividuals - CurrentevidencesuggeststhatIGRAperformsimilarlytotheTST atiden3fyingHIV+individualswhocouldbenetfromLTBI treatment - Importantques3onsremainunanswereddespitethesubstan3al bodyofliteratureonIGRAs: - HIV+individualswithanega3veIGRAresultmayhavealowriskof progressiontoac3veTB - IGRAs(par3cularlyTSPOT)maybemoresensi3vethanTSTinHIV- infectedindividualsandlessaectedbyadvancedimmunosuppression - ClinicalTrialsareneededtomoredeni3velydeterminewhetherIGRAs couldimprovetheiden3ca3onofpeoplelivingwithHIV - Un3lsuchdataareavailable,thedecisiontouseIGRAorTST(orboth) willdependonna3onalguidelinesaswellasresourceandogis3c considera3ons. 10. - Thediagnos3cvalueofinterferon-releaseassays(IGRAs)for ac3vetuberculosisinlow-andmiddle-incomecountriesis unclear - TherewasnoconsistentevidencethateitherIGRAwasmore sensi3vethanthetuberculinskintestforac3vetuberculosis diagnosis - Conclusions:neitherthetuberculinskintestnorIGRAshave valueforac3vetuberculosisdiagnosis,especiallyinthe contextofHIVcoinfec3on Interferon-ReleaseAssaysforAc;vePulmonary TuberculosisDiagnosis 11. Comparisonofsensi;vityofT-SPOTVSQFT-GIT amongpersonswithsuspectedac;vetuberculosis 12. Sensi;vityofQFT-GITandT-SPOTinHIV-andHIV +personswithconrmedac;vetuberculosis 13. Sensi;vitydierencebetweenIGRAandTST Plotsdisplay%dierences(IGRAsensi3vityTSTsensi3vity)forconrmedac3ve pulmonarytuberculosis 14. Interferon-ReleaseAssaysforAc;ve PulmonaryTuberculosisDiagnosis - AsinthecaseoftheTST,thedatasuggestnoroleforusing IGRAsforac3vetuberculosisdiagnosisforadultslivinginlow- andmiddle-incomecountries - Thesedatashouldnothelpinformevidence-basedpolicieson theroleofIGRAsinac3vetuberculosisdiagnosis - Indeed,aWHOExpertGroupconsideringthisevidencerecently recommendedthatIGRAsshouldnotbeusedasareplacement forconven3onalmicrobiologicaldiagnosisofpulmonaryand extrapulmonary 15. - Tuberculosisisuniqueamongthemajorinfec3ousdiseasesin thatitlacksaccuraterapidpoint-of-carediagnos3ctests - Failuretocontrolthespreadoftuberculosisislargelyduetoour inabilitytodetectandtreatallinfec3ouscasesofpulmonary tuberculosisina3melyfashion,allowingcon3nued Mycobacteriumtuberculosistransmissionwithincommuni3es 16. AnalysisofMtb-specicTcellresponsesinthe valida;oncohort 17. Quan;ta;veandqualita;veanalysisofMtb- specicTcellresponses Latentinfec3on Ac3vedisease 18. Func;onalproleofMtb-specicCD4+Tcells onthebasisofIFN-,IL-2orTNF-produc;on 19. PercentagesofCFP-10orESAT-6specic single-posi;veTNF-producingCD4+Tcells 20. ProleofMtb-specicCD4+Tcellsduring untreatedTBdiseaseandthenaZerTBtreatment 21. M.tuberculosisspecicCD4+Tcellresponses andlatentinfec;onorac;vedisease - Rapiddiagnosisofac3veMycobacteriumtuberculosis(Mtb) infec3onremainsaclinicalandlaboratorychallenge - WehaveanalyzedthecytokineproleIFN-,TNF-andIL-2 ofMtb-specicTcellsbypolychroma3cowcytometry - Substan3alincreaseinthepropor3onofsingle-posi3veTNF- Mtb-specicCD4+Tcellsinsubjectswithac3vedisease, andthisparameterwasthestrongestpredictorofdiagnosis ofac3vediseaseversuslatentinfec3on - Therefore,thepropor3onofsingle-posi3veTNF-Mtb- specicCD4+Tcellsisanewtoolfortherapiddiagnosisof ac3vetuberculosisdisease 22. DivisionofOnco-Haemathology,SanGerardo Hospital,UniversityMilano-Bicocca Monza,Italy LuisaVerga FaustoRossini PietroPioltelli EnricoPogliani DivisionofDivisionofPathology,SanGerardo Hospital, UniversityMilan-Bicocca Monza,Italy AmbrogioBrenna SerenaCu`n GiorgioCatore` DivisionofMicrobiologyandVirologyLaboratories, SanGerardoHospital,Monza,Italy SergioMalandrin AnnalisaCavallero HaemathologyandTransfusionCenter,San GerardoHospital,Monza,Italy PaoloPerseghin AriannaIncontri ChairofImmunology, UniversityofMilan,Milan,Italy DariaTrabaaoni MarinaSaresella MaraBiasin Mario(Mago)Clerici DepartmentofInfec;ousDiseases, L.SaccoHospital,UniversityofMilan Milan,Italy, FabioFranze` FabioZanini StefanoRusconi StefaniaPiconi GiulianoRizzardini ClinicofInfec;ousDiseases,SanPaoloHospital, UniversityofMilan Milan,Italy GiuliaMarche` CamillaTinca; AntonelladArminioMonforte DivisionediMala`eInfe`ve A.O.SanGerardo Monza GiuseppeLapadula SilviaCostarelli AlessandraBandera MariannaRossi NicolaSquillace AlessandroSoria AntonioMuscatello Sebas;anoLeone GuglielmoMigliorino 23. BACKUPSLIDES 24. InterferonGammaReleaseAssay(IGRA)tes;ng 25. summary curves from the HSROC model contain a summary operating point (red square) representing summarized sensitivity and specificity point estimates for individual study estimates (open circles). The 95% confidence region is delineated by the area in the orange dashed line.